Loredana Pettine

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Venues

American journal of hematology

Blood advances

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Bruno Fattizzo, Cristina Vercellati, Anna Marcello, Parija Patel, Megan Wind-Rotolo, Loredana Pettine, Marcella Bonanomi, Daniela Gaglio, Marta Bortolotti, Claudia Leoni, Elisa Fermo, Paola Bianchi, Anna Zaninoni, Francesco Passamonti, Wilma Barcellini
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study. American journal of hematology 99 (6) (2024)
Bruno Fattizzo, Cristina Vercellati, Anna Marcello, Parija Patel, Megan Wind-Rotolo, Loredana Pettine, Marcella Bonanomi, Daniela Gaglio, Marta Bortolotti, Claudia Leoni, Elisa Fermo, Paola Bianchi, Anna Zaninoni, Francesco Passamonti, Wilma Barcellini
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study. American journal of hematology 99 (6) (2024)
Bruno Fattizzo, Cristina Vercellati, Anna Marcello, Parija Patel, Megan Wind-Rotolo, Loredana Pettine, Marcella Bonanomi, Daniela Gaglio, Marta Bortolotti, Claudia Leoni, Elisa Fermo, Paola Bianchi, Anna Zaninoni, Francesco Passamonti, Wilma Barcellini
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study. American journal of hematology (2024)
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Alfredo Marchetti, Sonia Fabris, Stefania Pioggia, Ilaria Silvestris, Domenica Ronchetti, Silvia Lonati, Giuseppina Fabbiano, Valentina Traini, Elisa Taiana, Laura Porretti, Federico Simone Colombo, Claudio De Magistris, Margherita Scopetti, Marzia Barbieri, Loredana Pettine, Federica Torricelli, Antonino Neri, Francesco Passamonti, Marta Lionetti, Matteo Claudio Da Vià, Niccolo' Bolli
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis. Blood advances 8 (15) (2024)
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Alfredo Marchetti, Sonia Fabris, Stefania Pioggia, Ilaria Silvestris, Domenica Ronchetti, Silvia Lonati, Giuseppina Fabbiano, Valentina Traini, Elisa Taiana, Laura Porretti, Federico Simone Colombo, Claudio De Magistris, Margherita Scopetti, Marzia Barbieri, Loredana Pettine, Federica Torricelli, Antonino Neri, Francesco Passamonti, Marta Lionetti, Matteo Claudio Da Vià, Niccolo' Bolli
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis. Blood advances 8 (15) (2024)
Bruno Fattizzo, Cristina Vercellati, Anna Marcello, Parija Patel, Megan Wind-Rotolo, Loredana Pettine, Marcella Bonanomi, Daniela Gaglio, Marta Bortolotti, Claudia Leoni, Elisa Fermo, Paola Bianchi, Anna Zaninoni, Francesco Passamonti, Wilma Barcellini
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study. American journal of hematology 99 (6) (2024)
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Alfredo Marchetti, Sonia Fabris, Stefania Pioggia, Ilaria Silvestris, Domenica Ronchetti, Silvia Lonati, Giuseppina Fabbiano, Valentina Traini, Elisa Taiana, Laura Porretti, Federico Simone Colombo, Claudio De Magistris, Margherita Scopetti, Marzia Barbieri, Loredana Pettine, Federica Torricelli, Antonino Neri, Francesco Passamonti, Marta Lionetti, Matteo Claudio Da Via', Niccolo' Bolli
Inference of genomic lesions from single-cell RNAseq in myeloma improves functional intra- and inter-clonal analysis. Blood advances (2024)
Enrica Antonia Martino, Salvatore Palmieri, Monica Galli, Daniele Derudas, Roberto Mina, Roberta Della Pepa, Renato Zambello, Ernesto Vigna, Antonella Bruzzese, Silvia Mangiacavalli, Elena Zamagni, Catello Califano, Maurizio Musso, Concetta Conticello, Claudio Cerchione, Giuseppe Mele, Nicola Di Renzo, Massimo Offidani, Giuseppe Tarantini, Gloria Margiotta Casaluci, Angela Rago, Roberto Ria, Giuseppina Uccello, Gregorio Barilà, Gaetano Palumbo, Loredana Pettine, Iolanda Donatella Vincelli, Marino Brunori, Fabrizio Accardi, Valeria Amico, Angela Amendola, Raffaele Fontana, Velia Bongarzoni, Bernardo Rossini, Emilia Cotzia, Alessandro Gozzetti, Rita Rizzi, Nicola Sgherza, Giovanni Reddiconto, Antonio Maroccia, Luca Franceschini, Giuseppe Bertuglia, Davide Nappi, Emiliano Barbieri, Barbara Gamberi, Maria Teresa Petrucci, Francesco Di Raimondo, Antonino Neri, Fortunato Morabito, Pellegrino Musto, Massimo Gentile
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials. Hematological oncology 42 (4) (2024)
Enrica Antonia Martino, Salvatore Palmieri, Monica Galli, Daniele Derudas, Roberto Mina, Roberta Della Pepa, Renato Zambello, Ernesto Vigna, Antonella Bruzzese, Silvia Mangiacavalli, Elena Zamagni, Catello Califano, Maurizio Musso, Concetta Conticello, Claudio Cerchione, Giuseppe Mele, Nicola Di Renzo, Massimo Offidani, Giuseppe Tarantini, Gloria Margiotta Casaluci, Angela Rago, Roberto Ria, Giuseppina Uccello, Gregorio Barilà, Gaetano Palumbo, Loredana Pettine, Iolanda Donatella Vincelli, Marino Brunori, Fabrizio Accardi, Valeria Amico, Angela Amendola, Raffaele Fontana, Velia Bongarzoni, Bernardo Rossini, Emilia Cotzia, Alessandro Gozzetti, Rita Rizzi, Nicola Sgherza, Giovanni Reddiconto, Antonio Maroccia, Luca Franceschini, Giuseppe Bertuglia, Davide Nappi, Emiliano Barbieri, Barbara Gamberi, Maria Teresa Petrucci, Francesco Di Raimondo, Antonino Neri, Fortunato Morabito, Pellegrino Musto, Massimo Gentile
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials. Hematological oncology 42 (4) (2024)
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Alfredo Marchetti, Sonia Fabris, Stefania Pioggia, Ilaria Silvestris, Domenica Ronchetti, Silvia Lonati, Giuseppina Fabbiano, Valentina Traini, Elisa Taiana, Laura Porretti, Federico Simone Colombo, Claudio De Magistris, Margherita Scopetti, Marzia Barbieri, Loredana Pettine, Federica Torricelli, Antonino Neri, Francesco Passamonti, Marta Lionetti, Matteo Claudio Da Vià, Niccolo' Bolli
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis. Blood advances 8 (15) (2024)
Bruno Fattizzo, Giacinto Luca Pedone, Caterina Brambilla, Loredana Pettine, Anna Zaninoni, Francesco Passamonti, Wilma Barcellini
Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis. Blood advances (2023)
Bruno Fattizzo, Alfredo Marchetti, Anna Zaninoni, Marta Lionetti, Marta Riva, Lorenzo Rizzo, Loredana Pettine, Nicole Galli, Federico Mazzon, Elisa Fermo, Akihiro Maeda, Alessio Marella, Matteo Claudio Da Vià, Francesco Passamonti, Niccolò Bolli, Wilma Barcellini
Immunomodulatory cytokines and clonal dynamics in low-risk myelodysplastic syndromes patients treated with luspatercept. American journal of hematology (2023)
Loredana Pettine, Marta Bortolotti, Bruno Fattizzo, Matteo C Da Vià, Dario Consonni, Alessandra Pompa, Niccolò Bolli, Luca Baldini
Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients. Hematological oncology (2022)

Loredana Pettine.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Loredana Pettine